New AI-COVID Software Helps Clinical Labs to Rule-Out COVID-19
Image Credit: Gorodenkoff/shutterstock
Artificial intelligence could soon be added to the testing toolkits of hospital-based laboratories and doctors at the forefront of the COVID-19 pandemic.
Recent research by collaborators from the University of Vermont and Cedars-Sinai explains the performance of Biocogniv’s new AI-COVID™ software. The researchers discovered high precision in estimating the probability of COVID-19 infection during routine blood tests, which could enable hospitals to reduce the number of patients referred for scarce PCR testing.
Nine months into this pandemic, we now have a better understanding of how to care for patients with COVID-19, but there’s still a big bottleneck in COVID-19 diagnosis with PCR testing.
AI-COVID tool could help labs rule out COVID-19 theengineer.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theengineer.co.uk Daily Mail and Mail on Sunday newspapers.
Washington [US], December 11 (ANI): A recent study conducted with collaborators from the University of Vermont and Cedars-Sinai describes the performance of Biocogniv s new AI-COVID software.
The team found high accuracy in predicting the probability of COVID-19 infection using routine blood tests, which can help hospitals reduce the number of patients referred for scarce PCR testing.
Their study in the Journal of Medical Internet Research is available online. Nine months into this pandemic, we now have a better understanding of how to care for patients with COVID-19, said lead author and University of Vermont Assistant Professor Timothy Plante, M.D., M.H.S., but there s still a big bottleneck in COVID-19 diagnosis with PCR testing.
AI tool helps clinical labs to rule out COVID-19
Hospital-based laboratories and doctors at the front line of the COVID-19 pandemic might soon add artificial intelligence to their testing toolkit. A recent study conducted with collaborators from the University of Vermont and Cedars-Sinai describes the performance of Biocogniv s new AI-COVID™ software. The team found high accuracy in predicting the probability of COVID-19 infection using routine blood tests, which can help hospitals reduce the number of patients referred for scarce PCR testing.
Their study in the
/
e24048.
Nine months into this pandemic, we now have a better understanding of how to care for patients with COVID-19, but there s still a big bottleneck in COVID-19 diagnosis with PCR testing.
Related Company:
AI software uses routine blood work to assist clinical labs with COVID testing shortage
Vermont Business Magazine Hospital-based laboratories and doctors at the front line of the COVID-19 pandemic might soon add artificial intelligence to their testing toolkit. A recent study conducted with collaborators from the University of Vermont and Cedars-Sinai describes the performance of Biocogniv’s new AI-COVID software. The team found high accuracy in predicting the probability of COVID-19 infection using routine blood tests, which can help hospitals reduce the number of patients referred for scarce PCR testing.
Their study in the
“Nine months into this pandemic, we now have a better understanding of how to care for patients with COVID-19,” says lead author and University of Vermont Assistant Professor Timothy Plante, MD, “but there’s still a big bottleneck in COVID-19 diagnosis with PCR testing.”